Clinical Trial Update: An Innovative Conversational Agent (Quitbot) for Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial update describing Quitbot, a conversational agent for smoking cessation, with the study status listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Quitbot

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Cigarette Smoking-Related Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING